May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 29, 2024
University of Cincinnati Cancer Center experts will present research on ovarian and blood cancer trials, the link between poor sleep and cancer-related cognitive impairment, and an innovative youth education program at the American Society of Clinical Oncology annual meeting 2024 in Chicago.
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.
August 9, 2023
Dr. Leeya Pinder, is among the first named as Cancer Moonshot Scholars by the National Cancer Institute.
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.
October 23, 2023
The University of Cincinnati Cancer Center's Leeya Pinder joined Local 12's What's Happening in Health to discuss her Cancer Moonshot Scholars research project focused on cervical cancer prevention for women living with HIV in Zambia.
April 19, 2024
The University of Cincinnati's Leeya Pinder was featured in an Alabama.com/Reckon article about how self-testing for HPV could make preventative care more accessible to those facing the most barriers.
April 11, 2024
The University of Cincinnati Cancer Center is one of 25 sites across the country hosting the SHIP trial testing whether samples self-collected by patients for HPV testing are as accurate and effective as clinic-collected samples.
October 31, 2018
A new study co-authored by a University of Cincinnati (UC) resident physician and published in the Oct. 31 online edition of the New England Journal of Medicine shows that a non-invasive radical hysterectomy may lead to shorter survival rates than open surgery in women with early-stage cervical cancer.